Product Recalls in Delaware

Product recalls affecting Delaware — including food, drugs, consumer products, medical devices, and vehicles distributed to Delaware. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,674 recalls have been distributed to Delaware in the last 12 months.

48,330 total recalls
2,674 in last 12 months

Showing 47614780 of 13,379 recalls

DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Cyanocobalamin/Folinic Acid Injection Recalled by Fusion IV Pharmaceuticals,...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: AscorbiX (Buffered C) Injection Recalled by Fusion IV Pharmaceuticals, Inc....

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Dexamethasone (LA) Injectable Suspension Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Cyanocobalamin Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Levocarnitine Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Lysine Hydrochloride Injection Recalled by Fusion IV Pharmaceuticals, Inc....

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: B-COMPLEX 110 INJECTABLE Recalled by Fusion IV Pharmaceuticals, Inc. dba...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Mitomycin-C (PF) Irrigation Solution Recalled by Fusion IV Pharmaceuticals,...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Testosterone Cypionate Injection Recalled by Fusion IV Pharmaceuticals, Inc....

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Testosterone Cypionate Injection Recalled by Fusion IV Pharmaceuticals, Inc....

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Deoxycholic Acid Sodium Injection Recalled by Fusion IV Pharmaceuticals,...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Hydroxocobalamin Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2020· Pharmaceutical Associates Inc

Recalled Item: Nystatin Oral Suspension Recalled by Pharmaceutical Associates Inc Due to...

The Issue: Subpotent: Out of specification for assay at the 12-month time point.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2020· Hikma Pharmaceuticals USA Inc.

Recalled Item: methylPREDNISolone Sodium Succinate For Injection Recalled by Hikma...

The Issue: Labeling: Incorrect Instructions: Vial label incorrectly instructs...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 10, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets Recalled by Lupin...

The Issue: CGMP Deviations: Out of specification test result observed during...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 10, 2020· Advanced Accelerator Applications USA, Inc.

Recalled Item: NETSPOT Recalled by Advanced Accelerator Applications USA, Inc. Due to...

The Issue: Defective Container: loose aluminum cap crimp for the dilution buffer vial...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2020· AVKARE Inc.

Recalled Item: Dutasteride Capsules Recalled by AVKARE Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: High out of specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 26, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP...

The Issue: Failed Tablet/Capsule Specifications: Complaints related to crumbling of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund